Paper9099183
Duration of glutamate release after acute ischemic stroke.
Dávalos A and 3 others. Stroke, 1997. Cited by 155 papers, by iCite.
Cite this record
ConductScience Library. Duration of glutamate release after acute ischemic stroke. Papers, record 9099183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9099183
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Ischemia | Major topic |
| Cerebrovascular Disorders | Major topic |
| Glutamic Acid | Major topic |
| Acute Disease | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Disease Progression | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Time Factors |
Source PubMed
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42839011 | A roadmap towards clinical use of molecular biomarkers in acute ischaemic stroke. | Nat Rev Neurol | 2026 | https://conductscience.org/library/papers/42839011 | PubMed |
| 41353453 | Engineering localized injury: a 3D microfluidic platform approach for ex vivo tissue interrogation. | Anal Bioanal Chem | 2026 | https://conductscience.org/library/papers/41353453 | PubMed |
| 39942654 | The Study of the Protection Mechanism of Calycosin-7-O-β-d-Glucoside Against Oxygen-Glucose Deprivation/Reperfusion in HT22 Cells Based on Non-Targeted Metabolomics and Network Analysis. | Molecules | 2025 | https://conductscience.org/library/papers/39942654 | PubMed |
| 39874036 | Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical Reperfusion: The RODIN Randomized Clinical Trial. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/39874036 | PubMed |
| 39451997 | The Cerebrovascular Side of Plasticity: Microvascular Architecture across Health and Neurodegenerative and Vascular Diseases. | Brain Sci | 2024 | https://conductscience.org/library/papers/39451997 | PubMed |
| 38928260 | Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928260 | PubMed |
| 38568450 | Mitochondrial Calcium Uniporter (MCU) is Involved in an Ischemic Postconditioning Effect Against Ischemic Reperfusion Brain Injury in Mice. | Cell Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38568450 | PubMed |
| 38183680 | Brain energy metabolism: A roadmap for future research. | J Neurochem | 2024 | https://conductscience.org/library/papers/38183680 | PubMed |
| 38069049 | Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38069049 | PubMed |
| 37521710 | Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea. | Front Neurosci | 2023 | https://conductscience.org/library/papers/37521710 | PubMed |
| 37056305 | A retrospect and outlook on the neuroprotective effects of anesthetics in the era of endovascular therapy. | Front Neurosci | 2023 | https://conductscience.org/library/papers/37056305 | PubMed |
| 36158970 | Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke. | Front Neurol | 2022 | https://conductscience.org/library/papers/36158970 | PubMed |
| 36012745 | Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012745 | PubMed |
| 35806146 | Promising Strategies for the Development of Advanced In Vitro Models with High Predictive Power in Ischaemic Stroke Research. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806146 | PubMed |
| 35409182 | Melatonin-Induced Postconditioning Suppresses NMDA Receptor through Opening of the Mitochondrial Permeability Transition Pore via Melatonin Receptor in Mouse Neurons. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409182 | PubMed |
| 35289376 | Luminescent Human iPSC-Derived Neurospheroids Enable Modeling of Neurotoxicity After Oxygen-glucose Deprivation. | Neurotherapeutics | 2022 | https://conductscience.org/library/papers/35289376 | PubMed |
| 34300300 | Characterization of a Temporal Profile of Biomarkers as an Index for Ischemic Stroke Onset Definition. | J Clin Med | 2021 | https://conductscience.org/library/papers/34300300 | PubMed |
| 34165728 | Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers. | Transl Stroke Res | 2022 | https://conductscience.org/library/papers/34165728 | PubMed |
| 34102764 | 7T Magnetic Resonance Imaging Quantification of Brain Glutamate in Acute Ischaemic Stroke. | J Stroke | 2021 | https://conductscience.org/library/papers/34102764 | PubMed |
| 33505485 | Enriched Environment Promotes Cognitive Function Recovery following Cerebral Ischemic Injury via Upregulating GABAergic and Glutamatergic Systems in the Contralateral Hippocampus. | Evid Based Complement Alternat Med | 2020 | https://conductscience.org/library/papers/33505485 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9099183
GET https://conductscience.org/api/papers/v1/9099183/cited_by?page=2